You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 265 No. 15, April 17, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Disposition and Pharmacodynamics of Methamphetamine in Pregnant Sheep

David J. Burchfield, MD; Victor W. Lucas, MD; Robert M. Abrams, PhD; Ronald L. Miller; C. Lindsay DeVane, PharmD

JAMA. 1991;265(15):1968-1973.


Abstract

To determine the placental transfer of methamphetamine, its subsequent fetal disposition, and its hemodynamic effects, we administered methamphetamine intravenously to 15 pregnant ewes 3 days after placement of maternal and fetal vascular catheters. Methamphetamine crossed the placenta within 30 seconds of its administration. Although the ewes had higher peak concentrations, the fetuses' longer elimination half-life ultimately led to higher fetal than maternal methamphetamine concentrations. The ratio of fetal tissue to plasma drug concentration 2 hours after administration was highest in the lung, followed by the placenta, kidney, intestine, liver, brain, and heart. Methamphetamine caused a 54% to 63% rise in maternal blood pressure, a 20% to 37% increase in fetal blood pressure, and a drop in fetal oxyhemoglobin saturation and arterial pH. We conclude that methamphetamine, in doses at or below what is commonly abused, has effects that could be detrimental to the health of the mother and her fetus.

(JAMA. 1991;265:1968-1973)



Author Affiliations

From the Departments of Pediatrics (Drs Burchfield, Lucas, and Abrams), Obstetrics and Gynecology (Dr Abrams), Pharmacy Practice (Mr Miller and Dr DeVane), and Psychiatry (Dr DeVane), University of Florida, Gainesville.


Footnotes

Presented in abstract form at the fall meeting of the American Academy of Pediatrics, Boston, Mass, October 6-10,1990.

Reprint requests to Department of Pediatrics, Division of Neonatology, Box J-296, JHMHC, University of Florida, Gainesville, FL 32610 (Dr Burchfield).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methamphetamine detection in maternal and neonatal hair: implications for fetal safety
Garcia-Bournissen et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2007;92:351-355.
ABSTRACT | FULL TEXT  

The Infant Development, Environment, and Lifestyle Study: Effects of Prenatal Methamphetamine Exposure, Polydrug Exposure, and Poverty on Intrauterine Growth
Smith et al.
Pediatrics 2006;118:1149-1156.
ABSTRACT | FULL TEXT  

Gender-Dependent Enhanced Adult Neurotoxic Response to Methamphetamine following Fetal Exposure to the Drug
Heller et al.
J. Pharmacol. Exp. Ther. 2001;298:769-779.
ABSTRACT | FULL TEXT  

Spontaneous Locomotor Activity and Pharmacokinetics of Intravenous Methamphetamine and Its Metabolite Amphetamine in the Rat
Rivière et al.
J. Pharmacol. Exp. Ther. 1999;291:1220-1226.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.